Benjamin J. Hindson files SEC Form 4 disclosures for 10x Genomics, Inc.. They have made 45 open-market trades across 1 company since 2020, most recently 2026-08-24.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 45 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TXG | 488,182 | $36.3M |
Shares reported on the most recent Form 4, priced at the 2026-08-26 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TXG | SELL | 2026-08-24 | 2026-08-26 | $63.02 | $871K | +2.6% | — | — |
| TXG | SELL | 2026-05-22 | 2026-05-27 | $24.44 | $283K | +15.1% | +45.0% | +155.6% |
| TXG | SELL | 2026-02-23 | 2026-02-25 | $18.58 | $145K | +6.4% | -0.9% | +25.3% |
| TXG | SELL | 2025-11-24 | 2025-11-25 | $19.00 | $157K | -6.0% | -11.3% | +1.7% |
| TXG | SELL | 2025-08-22 | 2025-08-26 | $13.79 | $206K | -0.0% | -14.2% | +44.5% |
| TXG | SELL | 2025-05-22 | 2025-05-27 | $8.30 | $124K | +9.4% | +35.9% | +63.4% |
| TXG | SELL | 2025-02-24 | 2025-02-26 | $11.07 | $101K | -7.4% | -19.9% | -24.9% |
| TXG | SELL | 2024-11-22 | 2024-11-25 | $13.69 | $159K | +5.4% | -2.5% | -25.0% |
| TXG | SELL | 2024-08-22 | 2024-08-26 | $22.53 | $196K | -4.2% | -5.5% | -32.0% |
| TXG | SELL | 2024-05-22 | 2024-05-23 | $24.30 | $199K | -3.4% | -13.5% | +0.2% |
| TXG | SELL | 2024-02-22 | 2024-02-26 | $46.34 | $242K | -10.2% | -19.1% | -50.2% |
| TXG | SELL | 2023-11-22 | 2023-11-27 | $43.34 | $299K | +13.2% | +35.9% | +8.1% |
| TXG | SELL | 2023-08-22 | 2023-08-24 | $45.78 | $316K | +9.6% | -13.4% | -8.9% |
| TXG | SELL · 10b5-1 | 2023-08-01 | 2023-08-03 | $62.21 | $867K | -13.4% | -6.7% | -39.0% |
| TXG | SELL · 10b5-1 | 2023-07-19 | 2023-07-21 | $60.03 | $1.7M | -2.3% | -22.9% | -33.9% |
| TXG | SELL | 2023-05-23 | 2023-05-25 | $55.06 | $131K | +4.6% | +6.2% | -7.6% |
| TXG | SELL | 2023-02-22 | 2023-02-24 | $47.75 | $166K | +3.2% | +4.9% | +8.0% |
| TXG | SELL | 2022-11-22 | 2022-11-23 | $34.07 | $80K | -1.2% | -3.4% | +35.7% |
| TXG | SELL | 2022-08-23 | 2022-08-25 | $35.19 | $45K | -15.7% | -25.2% | -5.2% |
| TXG | SELL | 2022-05-23 | 2022-05-25 | $48.76 | $123K | +1.6% | +8.7% | -22.4% |
| TXG | SELL | 2022-02-22 | 2022-02-24 | $78.59 | $28K | -12.3% | -8.7% | -40.6% |
| TXG | SELL | 2022-01-03 | 2022-01-05 | $146.03 | $11.5M | -28.9% | -30.7% | -41.4% |
| TXG | SELL | 2021-12-01 | 2021-12-03 | $148.07 | $11.1M | +2.4% | +6.3% | -46.0% |
| TXG | SELL | 2021-11-22 | 2021-11-24 | $148.38 | $104K | -2.5% | -4.3% | -47.9% |
| TXG | SELL | 2021-11-01 | 2021-11-03 | $163.60 | $12.7M | -9.7% | -21.2% | -43.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.